ampicillin has been researched along with Acinetobacter Infections in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (6.94) | 18.7374 |
1990's | 7 (9.72) | 18.2507 |
2000's | 27 (37.50) | 29.6817 |
2010's | 28 (38.89) | 24.3611 |
2020's | 5 (6.94) | 2.80 |
Authors | Studies |
---|---|
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R | 1 |
Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE | 1 |
Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Arend, LNVS; Chaiben, V; Dantas, LR; de Andrade, AP; Ribeiro, VST; Suss, PH; Telles, JP; Tuon, FF; Yamada, CH | 1 |
El-Mashad, N; Elarabi, MA; Elmorshedi, M; Elsayed, E; Sherif, DA | 1 |
Assimakopoulos, SF; Christopoulou, I; Dimitriou, G; Gkentzi, D; Mamalis, I; Marangos, M; Paliogianni, F; Tsintoni, A | 1 |
Hakamifard, A; Naji Esfahani, SS; Shafiee, F; Soltani, R | 1 |
Dafopoulou, K; Pournaras, S; Tsakris, A | 1 |
Alebachew, M; Ayalneh, B; Demoz, GT; Legesse, Y | 1 |
Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
Abdelgani, S; Amir-Ronen, R; Geffen, Y; Liron, Y; Ohanyan, A; Paul, M; Raz-Pasteur, A | 1 |
Babaie, Z; Delfani, S; Mahdian, S; Norolahi, F; Rezaei, F; Shakib, P | 1 |
Hagihara, M; Housman, ST; Kuti, JL; Nicolau, DP | 1 |
Bahador, A; Hashemizadeh, Z; Mansoori, N; Pourakbari, B; Raoofian, R; Rostami, H; Taheri, M | 1 |
Costa, SF; Levin, AS; Oliveira, MS; Pedri, Ed; van der Heijden, I | 1 |
Hiraki, Y; Inoue, D; Kamimura, H; Karube, Y; Kawano, F; Masuda, Y; Takaki, K; Tsuji, Y; Yoshida, M | 1 |
Adnan, S; Lipman, J; Paterson, DL; Roberts, JA | 1 |
Ahmed, H; Awali, RA; Chaudary, K; Chopra, T; Hothi, J; Johnson, P; Kaye, KS; Krishna, A; Lephart, P; Marchaim, D; Pogue, JM; Slim, J; Tansek, R; Zhao, JJ | 1 |
Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C | 1 |
Leonard, DA; Mitchell, JM | 1 |
Çakmak, BÇ; Engür, D; Eyigör, M; Güzünler, M; Telli, M; Türkmen, MK | 1 |
Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A | 1 |
Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Leu, HS; Lin, HS; Ye, JJ | 1 |
Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
Akkoc, G; Atici, S; Bakir, M; Demir, SO; Karaaslan, A; Kepenekli, EK; Soysal, A; Yakut, N | 1 |
Aldridge, P; Busey, K; Ferreira, J; Guzman, N; Jankowski, CA; Johnson, D | 1 |
Carvalheira, A; Casquete, R; Silva, J; Teixeira, P | 1 |
Cevahir, N; Dirgen Caylak, S; Okke, D; Saçar, S; Sayin Kutlu, S; Süzer, T; Turgut, H | 1 |
Balbinot, A; Catavitello, C; D'Antonio, D; Di Bonaventura, G; Febbo, F; Piccolomini, R; Pompilio, A; Savini, V; Talia, M | 1 |
Chen, CL; Chia, JH; Chiu, CH; Lee, HY; Liu, SY; Su, LH; Tseng, LY | 1 |
Akins, R; Alangaden, G; Boikov, D; Chopra, T; Dhar, S; Kaye, KS; Marchaim, D; Navon-Venezia, S; Pogue, JM; Reddy, T; Salimnia, H; Selman, P | 1 |
Munsrichoom, A; Punpanich, W; Srisarang, S; Treeratweeraphong, V | 1 |
Clec'h, C; Cohen, Y; Jauréguy, F; Mellon, G; Picard, B | 1 |
Ozseven, AG; Ozseven, L; Sesli Çetin, E | 1 |
Berktaş, M; Ceylan, MR; Cıkman, A; Karahocagil, MK; Parlak, M | 1 |
Chankova, D; Dinev, N; Savov, E; Vatcheva, R | 1 |
Costa, SF; Levin, AS; Levy, CE; Manrique, AE; Medeiros, EA | 1 |
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
Rahal, JJ; Segal-Maurer, S; Urban, C | 1 |
Alkan, M; Almog, Y; Borer, A; Gilad, J; Porath, A; Riesenberg, K; Rimar, D; Schlaeffer, F; Smolyakov, R | 1 |
Horianopoulou, M; Kanellopoulou, M; Kyriakidis, A; Lambropoulos, S; Legakis, NJ; Paraskevopoulos, I | 1 |
Sandri, AM; Zavascki, AP | 1 |
Akín, R; Aydín, HI; Gökçay, E; Gülgün, M; Hacíhamdioğlu, D; Kendirli, T; Lenk, MK; Unay, B | 1 |
Chang, CY; Chang, YL; Hsu, CK; Hsueh, PR; Kuo, LC; Lai, CC; Liao, CH | 1 |
Betrosian, AP; Frantzeskaki, F; Georgiadis, G; Xanthaki, A | 1 |
Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I | 1 |
Durante-Mangoni, E; Fortunato, R; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
Kostakis, A; Lachanas, E; Miyakis, S; Sfyras, N; Tomos, P | 1 |
Betrosian, AP; Douzinas, EE; Frantzeskaki, F; Xanthaki, A | 1 |
Bernaldo de Quirós, JF; Moreno Torrico, A; Ruiz Palomar, J; Telenti Asensio, M | 1 |
Douboyas, J; Tsakris, A; Tzouvelekis, LS | 1 |
Avraham, I; Berger, BJ; Go, E; Mariano, N; Rahal, JJ; Rubin, D; Urban, C | 1 |
Becerril, B; Jiménez-Mejías, ME; Pachón, J; Palomino-Nicás, J; Revuelta, M; Rodríguez-Cobacho, A | 1 |
Bistoni, F; Bozza, S; Del Favero, A; Menichetti, F; Tascini, C | 1 |
Das, B; Goel, V; Kapil, A; Pandey, A; Seth, P; Sood, S | 1 |
Ardanuy, C; Ariza, J; Corbella, X; Gudiol, F; Pujol, M; Sora, M; Tubau, F; Vuelta, M | 1 |
Amyes, SG; Bello, H; Domínguez, M; González, G; Mella, S; Young, HK; Zemelman, R | 1 |
Jellison, TK; Mckinnon, PS; Rybak, MJ | 1 |
Hostacká, A | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Ackerman, BH; Cawley, MJ; Lee, S; Suh, C | 1 |
Levin, AS | 1 |
Bardowski, J; Dobrzański, WT; Kozak, W | 1 |
Yogev, R | 1 |
Azimi, P; Dunphy, MG; Hamstra, S; Kulhanjian, J; Levernier, K; Petru, A; Rankin, M | 1 |
Okoh, O | 1 |
Dederichs, M; Exss, R | 1 |
3 review(s) available for ampicillin and Acinetobacter Infections
Article | Year |
---|---|
Ampicillin/sulbactam: its potential use in treating infections in critically ill patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Sulbactam | 2013 |
Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Cardiopulmonary Bypass; Cross Infection; Debridement; Female; Humans; Mediastinitis; Middle Aged; Sulbactam; Surgical Wound Infection | 2008 |
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sulbactam | 2002 |
5 trial(s) available for ampicillin and Acinetobacter Infections
Article | Year |
---|---|
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cross Infection; Disk Diffusion Antimicrobial Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sulbactam; Treatment Outcome | 2007 |
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2008 |
Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Ampicillin; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sulbactam; Treatment Outcome | 1998 |
Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
Topics: Acinetobacter Infections; Adolescent; Ampicillin; Arthritis, Infectious; Ceftriaxone; Cellulitis; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Gonorrhea; Haemophilus Infections; Humans; Infant; Male; Osteomyelitis; Prospective Studies; Random Allocation; Staphylococcal Infections; Streptococcal Infections; Sulbactam | 1989 |
64 other study(ies) available for ampicillin and Acinetobacter Infections
Article | Year |
---|---|
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2008 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Biofilms; COVID-19; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Pandemics; Polymyxins; Sulbactam | 2022 |
Extensive drug resistant Acinetobacter baumannii: a comparative study between non-colistin based combinations.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Sulbactam; Tigecycline | 2020 |
Extensively-drug resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam | 2020 |
In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Colistin; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Changes in antimicrobial resistance of clinical isolates of Acinetobacter baumannii group isolated in Greece, 2010-2015.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Greece; Humans; Imipenem; Microbial Sensitivity Tests; Tertiary Care Centers; Tobramycin | 2018 |
Treatment of ventriculoperitoneal shunt infection and ventriculitis caused by Acinetobacter baumannii: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Cerebellar Neoplasms; Cerebral Ventriculitis; Child; Decompression, Surgical; Drug Resistance, Multiple, Bacterial; Humans; Hydrocephalus; Male; Medulloblastoma; Sulbactam; Ventriculoperitoneal Shunt | 2018 |
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Molecular Detection of Carbapenem Resistance in Acinetobacter Baumannii Isolated From Patients in Khorramabad City, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Iran; Microbial Sensitivity Tests; Sulbactam | 2020 |
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Minocycline; Models, Theoretical; Sulbactam; Tigecycline | 2013 |
Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Minocycline; Multiplex Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Rifampin; Sulbactam; Tertiary Healthcare; Tigecycline; Tobramycin | 2013 |
The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Sulbactam; Treatment Outcome; Young Adult | 2013 |
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Female; Humans; Meropenem; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Sulbactam; Thienamycins; Treatment Outcome | 2013 |
Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Michigan; Middle Aged; Retrospective Studies; Sulbactam | 2013 |
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 2014 |
Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Cross Infection; Humans; Protein Folding | 2014 |
A milk pump as a source for spreading Acinetobacter baumannii in a neonatal intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Breast Milk Expression; Cross Infection; Disease Outbreaks; Disease Reservoirs; Equipment Contamination; Humans; Incidence; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Male; Meropenem; Microbial Sensitivity Tests; Respiratory Distress Syndrome, Newborn; Sulbactam; Thienamycins | 2014 |
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2015 |
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Time Factors | 2015 |
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
Bacteremia due to Acinetobacter ursingii in infants: Reports of two cases.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Humans; Infant; Male; Opportunistic Infections; Sulbactam | 2016 |
Treatment efficacy of Ampicillin/Sulbactam in comparison to alternative beta-lactams for severe Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Female; Humans; Male; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome; Young Adult | 2016 |
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Chickens; Ciprofloxacin; Cross Infection; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Red Meat; Sulbactam; Swine; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
[Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Cerebrospinal Fluid; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Sulbactam; Treatment Outcome | 2008 |
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; beta-Lactam Resistance; Diagnostic Errors; Humans; Intensive Care Units; Sulbactam | 2009 |
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Integrons; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan | 2010 |
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Genotype; Humans; Imipenem; Michigan; Phylogeny; Prevalence; Retrospective Studies; Sulbactam; Urban Population | 2010 |
In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Child; Colistin; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Pediatric; Humans; Male; Microbial Sensitivity Tests; Sensitivity and Specificity; Sulbactam; Thailand | 2011 |
Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin.
Topics: Accidents, Traffic; Acinetobacter baumannii; Acinetobacter Infections; Adult; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Male; Meningitis, Bacterial; Postoperative Complications; Rifampin; Sulbactam | 2012 |
[Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2012 |
[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Microbial Sensitivity Tests; Sulbactam | 2013 |
In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Sulbactam | 2002 |
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Child; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Sulbactam | 2003 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Humans; Infection Control; Polymyxin B; Sulbactam | 2003 |
Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hospital Bed Capacity, 500 and over; Humans; Intensive Care Units; Israel; Male; Medical Records; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Polymerase Chain Reaction; Retrospective Studies; Risk Factors; Sulbactam | 2003 |
Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients.
Topics: Acinetobacter; Acinetobacter Infections; Administration, Inhalation; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bronchi; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Respiration, Artificial; Sulbactam | 2004 |
Restricting the use of ampicillin-sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Brazil; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Drug Utilization Review; Humans; Infection Control; Sulbactam | 2004 |
Meningitis with multidrug-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Meningitis; Sulbactam | 2004 |
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome | 2007 |
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam | 2007 |
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Italy; Microbial Sensitivity Tests; Rifampin; Sulbactam | 2007 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |
[The efficacy of sulbactam-ampicillin in a urinary infection due to Acinetobacter calcoaceticus var. anitratus].
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Cross Infection; Drug Evaluation; Drug Therapy, Combination; Humans; Prospective Studies; Sulbactam; Urinary Tract Infections | 1995 |
In-vitro activity of ampicillin/sulbactam against multiresistant Acinetobacter calcoaceticus var. anitratus clinical isolates.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Sulbactam | 1994 |
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.
Topics: Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Retrospective Studies; Sulbactam | 1993 |
Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Ampicillin; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Survival Rate; Treatment Outcome | 1997 |
Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymyxin B; Rifampin; Sulbactam | 1998 |
In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Clavulanic Acid; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Sulbactam | 1998 |
In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998.
Topics: Acinetobacter; Acinetobacter calcoaceticus; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Chile; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillins; Sulbactam | 2000 |
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacteremia; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Sulbactam; Treatment Outcome | 2001 |
In vitro effect of ampicillin/sulbactam on Acinetobacter species.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Hydrophobic and Hydrophilic Interactions; Lipase; Microbial Sensitivity Tests; Sulbactam; Surface Properties | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Meningitis, Bacterial; Middle Aged; Sulbactam | 2002 |
[Microbiological analysis of the results of treatment of urinary tract infections with epicillin].
Topics: Acinetobacter Infections; Ampicillin; Bacteriuria; Enterobacteriaceae Infections; Enterococcus faecalis; Follow-Up Studies; Humans; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections | 1979 |
Ventriculitis from Acinetobacter calcoaceticus variant anitratus.
Topics: Acinetobacter Infections; Ampicillin; Brain Diseases; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Female; Gentamicins; Humans; Infant, Newborn; Meningomyelocele; Postoperative Complications | 1979 |
[Mima polymorpha meningitis in a five month old infant and its treatment].
Topics: Acinetobacter Infections; Age Factors; Ampicillin; Female; gamma-Globulins; Gentamicins; Humans; Infant; Meningitis; Microbial Sensitivity Tests | 1971 |
[Bacterium antitratum meningitis in a small child (author's transl)].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Child, Preschool; Gentamicins; Humans; Male; Meningitis; Penicillin G; Penicillin Resistance | 1973 |